Benzamide, 3-((4-((4-((((5-(1,1-dimethylethyl)-2-methoxy-3-((methylsulfonyl)amino)phenyl)amino)carbonyl)amino)-1-naphthalenyl)oxy)-2-pyrimidinyl)amino)-5-ethynyl-N-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)-
TOP-1288 is under investigation in clinical trial NCT02888379 (Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis).